- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 7 - Immunotherapy: Where Is It At? Where Is It Headed?
Panelists Daniel J. George, MD, and Jeffrey Weber, MD, PhD, believe that while immunotherapy is still relatively new, this therapy option will play a promising role in the future for the treatment of cancer.
Immunotherapy is the most exciting area in cancer research right now, declares Dr George.
Dr George credits the IMPACT trial as a pivotal trial that led to the approval of Provenge, the first cellular immunotherapy approved by the FDA for the treatment of metastatic prostate cancer, and elaborates on the PSA quartile trial. He explains how the benefits of trials, in terms of overall survival and long-term disease-free survival with checkpoint inhibitors, help immunotherapy gain credibility for the treatment of cancer.
Dr Weber continues by highlighting current key trials featured during the ASCO 2013 meetings, which include trials for PD-1 antibodies, ipilimumab, and new combinations of ipilimumab with granulocyte-macrophage colony-stimulating factors (GM-CSFs).
George hopes that the results of key trials will help change the population of patients who can be treated with immunotherapy, as well as help providers treat patients in a more precise manner.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care
June 23rd 2025This research highlights the key factors, like leadership buy-in, mandatory protocols, and electronic health record workflows, that influence the effective collection of data on sexual orientation and gender identity in outpatient oncology clinics to improve patient-centered care.
Read More
